Respiratory sequelae in patients with bronchial asthma after SARS-CoV-2 pneumonia: a retrospective study in a large academic centre in 2020.

Respiratory sequelae in patients with bronchial asthma after SARS-CoV-2 pneumonia: a retrospective study in a large academic centre in 2020.

Publication date: Jan 01, 2025

Patients with asthma do not present more respiratory sequelae than a control population after SARS-CoV-2 pneumonia. However, patients with asthma do seem to present more symptoms and a distinct involvement of the airway https://bit. ly/47E6Hze.

Open Access PDF

Concepts Keywords
47e6hze Academic
Academic Asthma
Pneumonia Bronchial
Respiratory Centre
Symptoms Control
Cov
Large
Pneumonia
Population
Present
Respiratory
Retrospective
Sars
Sequelae
Symptoms

Semantics

Type Source Name
disease MESH sequelae
disease MESH bronchial asthma
disease MESH pneumonia
pathway KEGG Asthma
disease MESH SARS CoV 2 infection
disease MESH infection
drug DRUGBANK Carbon monoxide
drug DRUGBANK Oxygen
disease MESH eosinophilia
disease IDO blood
disease MESH allergy
pathway REACTOME Reproduction
disease MESH Rhinitis
disease MESH Rhinosinusitis
drug DRUGBANK Amlodipine
drug DRUGBANK Montelukast
drug DRUGBANK Azithromycin
drug DRUGBANK Lopinavir
drug DRUGBANK Ritonavir
drug DRUGBANK Tocilizumab
drug DRUGBANK Hydroxychloroquine
drug DRUGBANK Dexamethasone
disease MESH Chest pain
disease MESH tracheomalacia
disease MESH bronchiectasis

Original Article

(Visited 2 times, 1 visits today)